The further increase in autoverification rate from 99.0%
in 2010 to the current rate of 99.5% in 2013 was achieved
by allowing autoverification of critical values (provided
manual review limits or absurd ranges are not violated)
and by auto‑release of results with interference by
hemolysis, lipemia, or icterus. Exceeding interference
limits results in text result of “hemolyzed”, “lipemic”, or
“icteric” (i.e. no numeric result is provided), coupled with
crediting of charges for that assay. Tests cancelled due to
interference can only be overridden at clinician request,
with a disclaimer then appended. For critical values that
autoverify, the notification of clinical service occurs after
autoverification (i.e. as long as autoverification conditions
are met, filing of critical value results does not wait for
clinician notification).